Novel Treatments for Neuromuscular Disorders

 

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for muscle cramps, spasms and spasticity associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT). 

Spotlight

May 2, 2018 Flex Pharma Reports First Quarter 2018 Financial Results
Read More

March 26, 2018 Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in Multiple Sclerosis
Read More